Sol-Gel Technologies (SLGL) Enterprise Value (2016 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Enterprise Value came in at -$10.1 million in Q1 2026, up 40.03% year-on-year from -$7.2 million in Q1 2025, and up 57.76% on a QoQ basis from -$24.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Enterprise Value (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Enterprise Value data on file, last reported at -$10.1 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 40.03% year-over-year to -$10.1 million in Q1 2026; TTM through Mar 2026 was -$10.1 million, a 40.03% increase from a year earlier, with the FY2025 full-year figure at -$24.0 million, down 16.07% from the prior year.
- Enterprise Value for Q1 2026 stood at -$10.1 million, up from -$24.0 million in the prior quarter.
- Over the last five years, Enterprise Value for SLGL reached as high as -$6.7 million in Q3 2025 and fell as low as -$42.2 million in Q2 2022.
- Historically, Enterprise Value has averaged -$21.4 million across 5 years, with a median of -$20.7 million in 2025.
- Across the five-year window, Enterprise Value plunged 32.46% in 2023 and jumped 49.95% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$21.1 million in 2022, then slumped by 32.46% to -$28.0 million in 2023, then surged by 30.31% to -$19.5 million in 2024, then dropped by 23.07% to -$24.0 million in 2025, then jumped by 57.76% to -$10.1 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$10.1 million in Q1 2026, -$24.0 million in Q4 2025, and -$6.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | -10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.14 Mn |
| Dec 31, 2025 | -24.00 Mn |
| Sep 30, 2025 | -6.72 Mn |
| Jun 30, 2025 | -20.68 Mn |
| Mar 31, 2025 | -16.90 Mn |
| Dec 31, 2024 | -19.50 Mn |
| Sep 30, 2024 | -13.42 Mn |
| Jun 30, 2024 | -16.72 Mn |
| Mar 31, 2024 | -16.22 Mn |
| Dec 31, 2023 | -27.98 Mn |
| Sep 30, 2023 | -26.14 Mn |
| Jun 30, 2023 | -30.29 Mn |
| Mar 31, 2023 | -15.31 Mn |
| Dec 31, 2022 | -21.13 Mn |
| Sep 30, 2022 | -25.50 Mn |
| Jun 30, 2022 | -42.24 Mn |
| Mar 31, 2022 | -30.25 Mn |
| Dec 31, 2021 | -21.79 Mn |
| Sep 30, 2021 | -43.35 Mn |
| Jun 30, 2021 | -33.20 Mn |